Survodutide
Description
A novel dual glucagon receptor and GLP-1 receptor agonist peptide, researched for its targeted activation of hepatic lipolysis, metabolic rate elevation, and glycemic regulation in metabolic disease models.
Available in 6mg–12mg vials, every lot is third-party tested for identity and purity, with certificates of analysis available on request. Vials arrive sealed and sterile, lyophilized for stability, and ship from our U.S. facility in 2–6 days.
For in vitro laboratory research use only. See the Technical Data tab below for the full mechanism and feature summary.
Survodutide from Wolf Research is a high-purity research-grade compound intended strictly for laboratory research use.
Survodutide (Survodutide (dual GLP-1/glucagon receptor agonist)) is supplied as a research-grade compound for in vitro study of incretin and metabolic receptor signaling pathways. GLP-class research compounds are widely used in laboratory studies of glucose metabolism, appetite-related pathways, and receptor pharmacology.
Every lot of Survodutide is third-party tested for identity and purity, with certificates of analysis available on request. Supplied in sealed, sterile vials and shipped fast from our U.S. facility.
The products offered herein are intended exclusively for research purposes and must be utilized solely within in vitro environments (e.g., test tubes or laboratory settings) for the purposes of testing and experimentation. All information provided on this website is strictly for educational purposes and does not constitute legal or professional advice. It is imperative to acknowledge that the introduction of these products into humans or animals, in any capacity, is strictly prohibited by applicable laws and regulations. Violation of these regulations may result in legal repercussions. These products are intended solely for use by qualified, licensed professionals with the expertise to handle them safely and responsibly. Furthermore, it is important to note that these products are not classified as drugs, food, or cosmetics under any legal definitions. Any misbranding, misuse, or mislabeling of these products within these categories is expressly prohibited and may lead to further legal consequences. By adhering to these guidelines, you ensure compliance with all regulatory frameworks and contribute to the responsible conduct of scientific research.
Technical Data
| A novel dual glucagon receptor and GLP-1 receptor agonist peptide, researched for its targeted activation of hepatic lipolysis, metabolic rate elevation, and glycemic regulation in metabolic disease models. | |
|---|---|
| Key Benefits & Highlights | |
| Dual Receptor Agonism (GCGR / GLP-1R) | Simultaneously targets glucagon and GLP-1 receptors to provide balanced signaling across metabolic, hepatic, and appetite-regulating pathways. |
| Hepatic Fat Oxidation & Lipolysis | Glucagon receptor activation directly stimulates energy expenditure and liver fat oxidation, making it a key candidate for MASH and NAFLD research models. |
| Glycemic & Metabolic Control | GLP-1 receptor pathways support glucose-dependent insulin release, improved insulin sensitivity, and central satiety modulation. |
| Weight Dynamics & Energy Balance | Researched in cellular and animal models for its potential to drive substantial reductions in body weight through combined metabolic expenditure and appetite suppression. |
| High Chemical Purity | Synthesized and verified via analytical testing to ensure exact amino acid sequence fidelity and minimal experimental variance. |
| Standardized Research Reagent | Engineered for high reproducibility across in vitro receptor binding assays, metabolic pathway mapping, and obesity/hepatic disease research. |
| Feature Summary | |
| Product Class | Synthetic Dual-Agonist Peptide (Glucagon / GLP-1 Receptor Agonist) |
| Primary Application | In vitro dual-receptor kinetics, hepatic fat oxidation & metabolic regulation research |
| Grade | Laboratory / Research Grade Only |